By the conclusion of this activity, participants should be able to:

• Appraise new and upcoming technologies in the management of structural heart disease, including, valvular heart disease, stroke prevention, hemodynamic support, cardiomyopathy and high risk-percutaneous coronary intervention to determine their benefit for patients
• Evaluate the relative advantages and disadvantages of different strategies in complex cases involving valvulardisease
• Present indications, techniques, outcomes, and complications for transcathetervalve intervention in patients with native valvelesions
• Compare FDA approved technologies for TAVR and the scientific data supporting theiruse
• Examine best practice techniques for high certainty valveimplantation
• Analyze data and techniques for treatment of bioprosthetic valvedysfunction
• Evaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and the functionality of the team within a center ofexcellence
• Evoke the changing landscape of percutaneous and surgical techniques of valve repair and replacement
• Evaluate the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgicalinterventions
• Recognize the different diagnostic tools and combinations required to accurately diagnose specific structural heart diseases and plan transcathetertherapy
• Discuss rationale and technique of alternative access approach for aorticstenosis
• Discuss investigational valves in the near horizon including their therapeutic advantages and limitations
• Describe the advantages and pitfalls of comprehensive diagnostic techniques for patients with valvular heart disease such as cardiac computed tomography, three-dimensional echocardiography, and complex invasive hemodynamiccatheterization
• Discuss transcatheter treatment options for mitral valvedisease
• Explain the clinical data supporting mitral valve leaflet clip approximation for the treatment of mitralregurgitation
• Demonstrate and present best practice techniques for mitral valve clipapproximation
• Examine alternative investigational devices for the transcatheter treatment of mitral regurgitation
• Present alternatives with transcatheter aortic and pulmonic valve technologies for the treatment of mitraldisease
• Present progress in transcatheter mitral valvereplacement
• Present the techniques and efficacy of transcatheter treatment of mitral prosthetic valve paravalvularleaks
• Demonstrate how septal ablation and technologies can improve mitral regurgitation in hypertrophic cardiology.
• Discuss transcatheter treatment options for tricuspid valvediseaseExamine the evidence regarding closure of percutaneous closure of patent foramen ovale for stroke prevention.
• Examine the evidence regarding left atrial appendage exclusion for stroke prevention in patients with atrialfibrillation.
• Examinethedataandtechniquesforidentificationandassessmentofhemodynamically significant coronary arterylesions.
• Examine the data and techniques for coronary imaging and lesioncharacterization.Examine the data and techniques regarding new stent and bio-absorbable scaffolds for percutaneous coronary intervention, as well as devices for coronary intervention facilitation (plaque modification, chronic total occlusion).
• Examine the data and techniques for the treatment of in-stent re-stenosis, with emphasizes in new technology.
• Discuss therapeutic alternatives in patients with atrial fibrillation and the data to supportit.
• Identify the indication, techniques and complications for left atrial appendage occlusion in patients with afib.
• Recognize the risks and benefits of anticoagulation in patients with atrial fibrillation and other co-morbidities.
• Identify the role for catheter ablation for patients with atrial fibrillation based on the most recent trial
• Recognize the pathophysiology of atrial fibrillation and potential for new therapeutic targets.
• Learn and evaluate patients for advanced heart failure therapies.
• Focused learning related to multi organ transplant and special heart transplant patient population.
• Evaluation and basic management of patient with mechanical circulatory support devices including LVADs and Total artificial heart.
• Case based scenarios discussing complex advanced heart failure patients.